48
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The Effect of Microbiota and the Immune System on the Development and Organization of the Enteric Nervous System

      review-article
      ,
      Gastroenterology
      W.B. Saunders
      Enteric Nervous System (ENS), Microbiota, Neuroimmune Interaction, Parkinson’s Disease, Microbiota–Gut–Brain Axis, BMP, bone morphogenetic protein, BSH, bile salt hydrolase, CNS, central nervous system, EC, enterochromaffin cell, EGC, enteric glial cell, ENS, enteric nervous system, GF, germ-free, GLP-1, glucagon-like peptide-1, GI, gastrointestinal, 5-HT, 5-hydroxytryptamine, IBS, irritable bowel syndrome, MCT, monocarboxylate transporter, MGB, microbiota–gut–brain, MM, muscularis macrophage, nNOS, neuronal nitric oxide synthase, PD, Parkinson’s disease, RSD, resistant starch diet, SCFA, short-chain fatty acid, SERT, serotonin-selective reuptake transporter, TLR, Toll-like receptor

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The gastrointestinal (GI) tract is essential for the absorption of nutrients, induction of mucosal and systemic immune responses, and maintenance of a healthy gut microbiota. Key aspects of gastrointestinal physiology are controlled by the enteric nervous system (ENS), which is composed of neurons and glial cells. The ENS is exposed to and interacts with the outer (microbiota, metabolites, and nutrients) and inner (immune cells and stromal cells) microenvironment of the gut. Although the cellular blueprint of the ENS is mostly in place by birth, the functional maturation of intestinal neural networks is completed within the microenvironment of the postnatal gut, under the influence of gut microbiota and the mucosal immune system. Recent studies have shown the importance of molecular interactions among microbiota, enteric neurons, and immune cells for GI homeostasis. In addition to its role in GI physiology, the ENS has been associated with the pathogenesis of neurodegenerative disorders, such as Parkinson’s disease, raising the possibility that microbiota–ENS interactions could offer a viable strategy for influencing the course of brain diseases. Here, we discuss recent advances on the role of microbiota and the immune system on the development and homeostasis of the ENS, a key relay station along the gut–brain axis.

          Related collections

          Most cited references43

          • Record: found
          • Abstract: found
          • Article: not found

          The maternal microbiota drives early postnatal innate immune development.

          Postnatal colonization of the body with microbes is assumed to be the main stimulus to postnatal immune development. By transiently colonizing pregnant female mice, we show that the maternal microbiota shapes the immune system of the offspring. Gestational colonization increases intestinal group 3 innate lymphoid cells and F4/80(+)CD11c(+) mononuclear cells in the pups. Maternal colonization reprograms intestinal transcriptional profiles of the offspring, including increased expression of genes encoding epithelial antibacterial peptides and metabolism of microbial molecules. Some of these effects are dependent on maternal antibodies that potentially retain microbial molecules and transmit them to the offspring during pregnancy and in milk. Pups born to mothers transiently colonized in pregnancy are better able to avoid inflammatory responses to microbial molecules and penetration of intestinal microbes.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The microbiota regulates neutrophil homeostasis and host resistance to Escherichia coli K1 sepsis in neonatal mice

            Acquisition of microbes by the neonate, which begins immediately during birth, is influenced by gestational age and mother’s microbiota and modified by exposure to antibiotics 1 . In neonates, prolonged duration of antibiotic therapy is associated with increased risk of sepsis after 4 days of life, known as late-onset sepsis (LOS) 2 , a disorder critically controlled by neutrophils 3 , but a role for the microbiota in regulating neutrophil behavior in the neonate has not been described. We exposed pregnant mouse dams to antibiotics in drinking water to limit transfer of maternal microbes to the neonates. Antibiotic exposure of dams decreased the total number of microbes in the intestine, altered the structure of intestinal microbiota and changed the pattern of microbial colonization. These changes were associated with decreased numbers of circulating and bone marrow neutrophils and granulocyte/macrophage restricted progenitor cells in the bone marrow. Antibiotic-exposure of dams attenuated the postnatal granulocytosis by reducing the number of interleukin (IL) 17-producing cells in intestine and consequent production of granulocyte colony stimulating factor (G-CSF). Relative granulocytopenia contributed to increased susceptibility of antibiotic-exposed neonatal mice to Escherichia coli K1 and Klebsiella pneumoniae sepsis, which could be partially reversed by administration of G-CSF. Restoration of normal microbiota, through TLR4- and MYD88-dependent mechanism, induced accumulation of IL17-producing type 3 innate lymphoid cells (ILC) in the intestine, promoted granulocytosis, and restored the IL17-dependent resistance to sepsis. Specific depletion of ILCs prevented the IL17- and G-CSF-dependent granulocytosis and resistance to sepsis. These data support a role for the intestinal microbiota in regulation of granulocytosis and host resistance to sepsis in the neonates.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              GPR41/FFAR3 and GPR43/FFAR2 as cosensors for short-chain fatty acids in enteroendocrine cells vs FFAR3 in enteric neurons and FFAR2 in enteric leukocytes.

              The expression of short-chain fatty acid receptors GPR41/FFAR3 and GPR43/ free fatty acid receptor 2 (FFAR2) was studied in the gastrointestinal tract of transgenic monomeric red fluorescent protein (mRFP) reporter mice. In the stomach free fatty acid receptor 3 (FFAR3)-mRFP was expressed in a subpopulation of ghrelin and gastrin cells. In contrast, strong expression of FFAR3-mRFP was observed in all cholecystokinin, glucose-dependent insulinotropic peptide (GIP), and secretin cells of the proximal small intestine and in all glucagon-like peptide-1 (GLP-1), peptide YY, and neurotensin cells of the distal small intestine. Throughout the colon and rectum, FFAR3-mRFP was strongly expressed in the large population of peptide YY and GLP-1 cells and in the neurotensin cells of the proximal colon. A gradient of expression of FFAR3-mRFP was observed in the somatostatin cells from less than 5% in the stomach to more than 95% in the rectum. Substance P-containing enterochromaffin cells displayed a similar gradient of FFAR3-mRFP expression throughout the small intestine. Surprisingly, FFAR3-mRFP was also expressed in the neuronal cells of the submucosal and myenteric ganglia. Quantitative PCR analysis of fluorescence-activated cell sorting (FACS) purified FFAR3-mRFP positive cells confirmed the coexpression with the various peptide hormones as well as key neuronal marker proteins. The FFAR2-mRFP reporter was strongly expressed in a large population of leukocytes in the lamina propria of in particular the small intestine but surprisingly only weakly in a subpopulation of enteroendocrine cells. Nevertheless, synthetic ligands specific for either FFAR3 or FFAR2 each released GLP-1 from colonic crypt cultures and the FFAR2 agonist mobilized intracellular Ca²⁺ in FFAR2 positive enteroendocrine cells. It is concluded that FFAR3-mRFP serves as a useful marker for the majority of enteroendocrine cells of the small and large intestine and that FFAR3 and FFAR2 both act as sensors for short-chain fatty acids in enteroendocrine cells, whereas FFAR3 apparently has this role alone in enteric neurons and FFAR2 in enteric leukocytes.
                Bookmark

                Author and article information

                Contributors
                Journal
                Gastroenterology
                Gastroenterology
                Gastroenterology
                W.B. Saunders
                0016-5085
                1528-0012
                1 November 2016
                November 2016
                : 151
                : 5
                : 836-844
                Affiliations
                [1]The Francis Crick Institute, London, United Kingdom
                Author notes
                [] Reprint requests Address requests for reprints to: Vassilis Pachnis, MD, PhD, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, United Kingdom.The Francis Crick Institute1 Midland RoadLondon NW1 1ATUnited Kingdom Vassilis.Pachnis@ 123456crick.ac.uk
                Article
                S0016-5085(16)34896-X
                10.1053/j.gastro.2016.07.044
                5102499
                27521479
                3737b805-046c-4748-b96e-b3d652f3d290
                © 2016 The AGA Institute All rights reserved.

                This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).

                History
                : 13 April 2016
                : 7 July 2016
                Categories
                Reviews and Perspectives
                Brief Review

                Gastroenterology & Hepatology
                enteric nervous system (ens),microbiota,neuroimmune interaction,parkinson’s disease,microbiota–gut–brain axis,bmp, bone morphogenetic protein,bsh, bile salt hydrolase,cns, central nervous system,ec, enterochromaffin cell,egc, enteric glial cell,ens, enteric nervous system,gf, germ-free,glp-1, glucagon-like peptide-1,gi, gastrointestinal,5-ht, 5-hydroxytryptamine,ibs, irritable bowel syndrome,mct, monocarboxylate transporter,mgb, microbiota–gut–brain,mm, muscularis macrophage,nnos, neuronal nitric oxide synthase,pd, parkinson’s disease,rsd, resistant starch diet,scfa, short-chain fatty acid,sert, serotonin-selective reuptake transporter,tlr, toll-like receptor

                Comments

                Comment on this article